GlassScriptPrepare for your visit
Emily Lynch
Family · North Kansas City, MO · NPI 1568901296
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$482.99
in general payments reported to CMS, 2019-2025 · $161 in 2025
The $161 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Who reported paying
General payments only, top 6 by amount.
- Abbott Laboratories $90.83
- Astrazeneca Pharmaceuticals LP $68.75
- Novo Nordisk INC $53.56
- Novartis Pharmaceuticals Corporation $47.77
- Alnylam Pharmaceuticals INC. $45.81
- Melinta Therapeutics, LLC $32.84
Drugs and devices associated with these payments
Wainua Wegovy Leqvio Cardiomems Amvuttra Eterna Lifevest Mounjaro Zepbound Jardiance Repatha
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Emily Lynch listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10617689/emily-lynch